Behavioral Finance

May 19, 2026

Infographic titled 'James Montier’s Modified C-Score' with a horizontal bar chart of FY20–FY25, highlighting FY25 in green. The chart shows stacked values ending values like 3.2, 2.8, 2.1, 1.6, 1.3, and 1.1.

James Montier’s Modified C-Score: The 6-Variable Cooking-the-Books Detector That Complements Beneish M-Score and Piotroski F-Score

James Montier's Modified C-Score is a six-variable forensic detector for accounting manipulation. We decode all six variables, contrast a disciplined manufacturer with a generic red-flag profile, and show how Titan Biotech FY25's audited numbers score 0/6 — an educational illustration only, not a buy/sell recommendation.

May 19, 2026

Website hero with title 'Capacity to Suffer' and subtitle, plus a two-by-two grid: Trader (gray), Drift (light gray), Compounder (green), Speculator (orange).

Capacity to Suffer: Tom Russo’s Doctrine on Why Long-Term Compounders Tolerate Short-Term Reported-Earnings Drag

Tom Russo's Capacity to Suffer concept names the rarest corporate trait: management willingness to depress today's reported earnings to fund tomorrow's moat. Illustrated with Titan Biotech FY25 audited markers.

May 18, 2026

Infographic titled The Bias Blind Spot with four labeled blocks: Lucky (grey), Disciplined Investor (green), Confused (light grey), Bias-Trapped (orange) on a dark blue page.

The Bias Blind Spot: Pronin, Lin & Ross (2002)

Pronin, Lin & Ross's 2002 Stanford research on the meta-bias that hides every other cognitive error — why education makes the blind spot worse, the SEBI F&O data that shows ₹1.81 lakh crore of Indian retail losses for what they really are, the six external-structure counter-measures, and how Titan Biotech's FY25 governance architecture (4 of 11 independent directors, 14 board meetings, CFO/OP at 103%, contingent liabilities down 39.7%) illustrates the institutional version of Munger's iron prescription.

May 18, 2026

Hero banner with title 'Vigil Mechanism & Whistleblower Policy Disclosures' and a green FY21–FY25 timeline on dark blue background, conveying process milestones.

Vigil Mechanism & Whistleblower Policy Disclosures: SEBI LODR Regulation 22 and Companies Act §177(9)

How to read the Vigil Mechanism / Whistleblower Policy section of an Indian Annual Report — the three overlapping laws, the five-component checklist, and what Titan Biotech FY25's governance markers illustrate. Educational only — not a buy/sell call.